In IMT, ROS1 fusion was reported in about 10% of cases to date, and fusions of ROS1 with SLC12A2, YWHAE1, TFG, and FN1 have been described previously [4–6, 8, 11, 18]. This evidence concerns the gene ROS1 and inflammatory myofibroblastic tumor.